Light Mode
$0.1050 ↓ -0.0050 (-4.55%) Trading Down from the previous close of $0.1100, and at the day’s high of $0.1096
-0.10 (-48.02%) / 6M
Momentum, market sentiment, and recent alerts
IZOZF reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Izotropic Corp. is engaged in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. Its initial plan was to complete the engineering of the first imaging device and seek approval in the USA as a diagnostic device for detecting breast cancers. The company was founded by John M. Boone and Robert Louis Thast on May 19, 2016, and is headquartered in Surrey, Canada.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.